Published in Transl Stroke Res on September 20, 2013
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms | NCT02638701
Unruptured intracranial aneurysms: development, rupture and preventive management. Nat Rev Neurol (2016) 1.38
Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets. Transl Stroke Res (2014) 0.90
Modulating the Immune Response Towards a Neuroregenerative Peri-injury Milieu After Cerebral Hemorrhage. J Neuroimmune Pharmacol (2015) 0.84
Angiotensin-(1-7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: Role of the NFкB inflammatory pathway. Vascul Pharmacol (2015) 0.80
Endocannabinoids in cerebrovascular regulation. Am J Physiol Heart Circ Physiol (2016) 0.79
Anti-inflammatory signaling: the point of convergence for medical gases in neuroprotection against ischemic stroke. Med Gas Res (2016) 0.75
Myeloperoxidase is increased in human cerebral aneurysms and increases formation and rupture of cerebral aneurysms in mice. Stroke (2015) 0.75
Delayed morbidity and mortality in aneurysmal subarachnoid hemorrhage patients: effect of attenuating cerebral vasospasm. Neurol Sci (2014) 0.75
Preemptive Medicine for Cerebral Aneurysms. Neurol Med Chir (Tokyo) (2016) 0.75
Endovascular Management of Intracranial Aneurysms: Advances in Stenting Techniques and Technology. J Cerebrovasc Endovasc Neurosurg (2015) 0.75
Role of endothelial progenitor cells in cerebral aneurysm pathogenesis. Neurol Sci (2014) 0.75
Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice. Hypertension (2016) 0.75
Association of TNF-α-3959T/C Gene Polymorphisms in the Chinese Population with Intracranial Aneurysms. J Mol Neurosci (2017) 0.75
Screening of Critical Genes and MicroRNAs in Blood Samples of Patients with Ruptured Intracranial Aneurysms by Bioinformatic Analysis of Gene Expression Data. Med Sci Monit (2017) 0.75
Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res (2003) 3.99
Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol (2003) 3.69
Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation (2005) 3.12
Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J Biol Chem (2004) 2.94
A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation (2002) 2.76
Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro. Circ Res (2007) 2.55
Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res (2005) 2.45
Gamma Knife surgery for incidental cerebral arteriovenous malformations. J Neurosurg (2014) 2.44
Endoscopic endonasal versus open transcranial resection of anterior midline skull base meningiomas. World Neurosurg (2011) 2.38
Molecular determinants of vascular smooth muscle cell diversity. Circ Res (2005) 2.33
Potential intracranial applications of magnetic resonance-guided focused ultrasound surgery. J Neurosurg (2012) 2.32
Conditional deletion of Krüppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ Res (2008) 2.30
The role of preoperative embolization for intracranial meningiomas. J Neurosurg (2013) 2.29
Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res (2012) 2.28
Endovascular treatment of proximal and distal posterior inferior cerebellar artery aneurysms. J Neurosurg (2013) 2.23
Smooth muscle cell plasticity: fact or fiction? Circ Res (2012) 2.18
Rapid and progressive venous thrombosis after occlusion of high-flow arteriovenous fistula. World Neurosurg (2012) 2.17
C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation (2003) 2.16
Forced expression of myocardin is not sufficient for induction of smooth muscle differentiation in multipotential embryonic cells. Arterioscler Thromb Vasc Biol (2004) 2.09
Transcranial magnetic resonance-guided focused ultrasound surgery for trigeminal neuralgia: a cadaveric and laboratory feasibility study. J Neurosurg (2012) 2.04
Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. J Clin Invest (2006) 2.04
Aneurysmal subarachnoid hemorrhage in patients under 35-years-old: a single-center experience. Clin Neurol Neurosurg (2012) 2.01
Smooth muscle cells and myofibroblasts use distinct transcriptional mechanisms for smooth muscle alpha-actin expression. Circ Res (2007) 2.00
Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol (2011) 1.98
Transforming growth factor-beta1 signaling contributes to development of smooth muscle cells from embryonic stem cells. Am J Physiol Cell Physiol (2004) 1.93
Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am J Physiol Cell Physiol (2006) 1.91
Concise review: epigenetic mechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells. Stem Cells (2006) 1.80
Chiari I malformation in the very young child: the spectrum of presentations and experience in 31 children under age 6 years. Pediatrics (2002) 1.78
Biology of intracranial aneurysms: role of inflammation. J Cereb Blood Flow Metab (2012) 1.73
Standards for reporting randomized controlled trials in neurosurgery. J Neurosurg (2010) 1.71
Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice. J Clin Invest (2011) 1.70
Excitation-transcription coupling in arterial smooth muscle. Circ Res (2006) 1.70
Long-term outcomes and prognostic factors in pediatric patients with severe traumatic brain injury and elevated intracranial pressure. J Neurosurg Pediatr (2008) 1.69
Treatment of posterior circulation aneurysms with the pipeline embolization device. Neurosurgery (2013) 1.69
The role of radiotherapy following gross-total resection of atypical meningiomas. J Neurosurg (2012) 1.67
Perioperative management of patients undergoing transsphenoidal pituitary surgery. Anesth Analg (2005) 1.66
Influence of weekend versus weekday hospital admission on mortality following subarachnoid hemorrhage. Clinical article. J Neurosurg (2009) 1.66
PRISM/PRDM6, a transcriptional repressor that promotes the proliferative gene program in smooth muscle cells. Mol Cell Biol (2006) 1.65
Programming smooth muscle plasticity with chromatin dynamics. Circ Res (2007) 1.63
Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage. Neurosurgery (2008) 1.63
Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of craniopharyngiomas. World Neurosurg (2011) 1.62
5' CArG degeneracy in smooth muscle alpha-actin is required for injury-induced gene suppression in vivo. J Clin Invest (2005) 1.62
Endoscopic endonasal compared with anterior craniofacial and combined cranionasal resection of esthesioneuroblastomas. World Neurosurg (2012) 1.56
Characterization of perioperative seizures and epilepsy following aneurysmal subarachnoid hemorrhage. J Neurosurg (2003) 1.56
Stent-assisted coiling of intracranial aneurysms: predictors of complications, recanalization, and outcome in 508 cases. Stroke (2013) 1.54
Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J Thorac Cardiovasc Surg (2009) 1.53
Single-center experience with a dual microcatheter technique for the endovascular treatment of wide-necked aneurysms. J Neurosurg (2014) 1.52
Dural arteriovenous fistulas: a review of the literature and a presentation of a single institution's experience. World Neurosurg (2012) 1.50
Moyamoya disorder in the United States. Neurosurgery (2012) 1.50
Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2O2. Hypertension (2005) 1.49
Anterior-to-posterior circulation approach for mechanical thrombectomy of an acutely occluded basilar artery using the penumbra aspiration system. World Neurosurg (2011) 1.48
Is packing density important in stent-assisted coiling? Neurosurgery (2012) 1.47
Influence of weekend hospital admission on short-term mortality after intracerebral hemorrhage. Stroke (2009) 1.46
Kruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids. Am J Physiol Cell Physiol (2008) 1.46
Risk of hemorrhagic complication associated with ventriculoperitoneal shunt placement in aneurysmal subarachnoid hemorrhage patients on dual antiplatelet therapy. J Neurosurg (2013) 1.46
Detection of histone modifications at specific gene loci in single cells in histological sections. Nat Methods (2013) 1.46
Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters. Am J Physiol Cell Physiol (2006) 1.44
Stent-assisted endovascular recanalization of extracranial internal carotid artery occlusion in acute ischemic stroke. World Neurosurg (2012) 1.44
A novel endovascular technique for temporary balloon occlusion and permanent vessel deconstruction with a single microcatheter. World Neurosurg (2012) 1.42
Combinatorial control of smooth muscle-specific gene expression. Arterioscler Thromb Vasc Biol (2003) 1.42
Prophylactic antiepileptic drug therapy in patients undergoing supratentorial meningioma resection: a systematic analysis of efficacy. J Neurosurg (2011) 1.40
Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes. Am J Physiol Heart Circ Physiol (2004) 1.40
Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke (2011) 1.38
Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol (2008) 1.37
Comparison of flow diversion and coiling in large unruptured intracranial saccular aneurysms. Stroke (2013) 1.33
Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle. Am J Physiol Heart Circ Physiol (2009) 1.32
Assessment of contractility of purified smooth muscle cells derived from embryonic stem cells. Stem Cells (2006) 1.29
Successful treatment of a traumatic carotid pseudoaneurysm with the Pipeline stent: Case report and review of the literature. Surg Neurol Int (2012) 1.24
Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration. Circ Res (2009) 1.23
Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation. Arterioscler Thromb Vasc Biol (2013) 1.23
Endovascular obliteration of an intracranial pseudoaneurysm: the utility of Onyx. J Neurosurg Pediatr (2009) 1.21
Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma. J Neurosurg Pediatr (2012) 1.19
Stereotactic radiosurgery for intracranial dural arteriovenous fistulas: a systematic review. J Neurosurg (2014) 1.17
Early change in ferumoxytol-enhanced magnetic resonance imaging signal suggests unstable human cerebral aneurysm: a pilot study. Stroke (2012) 1.17
Origin of neointimal smooth muscle: we've come full circle. Arterioscler Thromb Vasc Biol (2006) 1.17
Safety and efficacy of endovascular treatment of basilar tip aneurysms by coiling with and without stent assistance: a review of 235 cases. Neurosurgery (2012) 1.16
Myocardin and Prx1 contribute to angiotensin II-induced expression of smooth muscle alpha-actin. Circ Res (2004) 1.15
Macrophage imbalance (M1 vs. M2) and upregulation of mast cells in wall of ruptured human cerebral aneurysms: preliminary results. J Neuroinflammation (2012) 1.15
Critical role of TNF-α in cerebral aneurysm formation and progression to rupture. J Neuroinflammation (2014) 1.15
Geographic variation and regional trends in adoption of endovascular techniques for cerebral aneurysms. J Neurosurg (2011) 1.14
Pitx2 is functionally important in the early stages of vascular smooth muscle cell differentiation. J Cell Biol (2008) 1.14
Smooth muscle alpha-actin gene requires two E-boxes for proper expression in vivo and is a target of class I basic helix-loop-helix proteins. Circ Res (2003) 1.13
Strict glucose control does not affect mortality after aneurysmal subarachnoid hemorrhage. Anesthesiology (2009) 1.13
Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation. Arterioscler Thromb Vasc Biol (2012) 1.12
Delayed goblet cell hyperplasia, acetylcholine receptor expression, and worm expulsion in SMC-specific IL-4Ralpha-deficient mice. PLoS Pathog (2007) 1.12
PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns. Am J Physiol Heart Circ Physiol (2008) 1.12
Bone marrow-derived MCP1 required for experimental aortic aneurysm formation and smooth muscle phenotypic modulation. J Thorac Cardiovasc Surg (2011) 1.11
Outcome following decompressive craniectomy in children with severe traumatic brain injury: a 10-year single-center experience with long-term follow up. J Neurosurg (2007) 1.10
Myocardin is differentially required for the development of smooth muscle cells and cardiomyocytes. Am J Physiol Heart Circ Physiol (2011) 1.10